Rigel Pharmaceuticals (RIGL) has disclosed a new risk, in the Share Price & Shareholder Rights category. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong ...

He has described it as an information management tool that gives police a way to better allocate their time and money. Rossmo has explained that geographic profiling can never solve a case alone. It ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Rigel Pharmaceuticals (RIGL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Rigel Pharmaceuticals (RIGL) announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and Hetero USA resolving patent litigation related to ...

Rigel Pharmaceuticals also announced a $10 million agreement with Kissei to develop Rezlidhia in Asia, with potential future payments reaching up to $152 million. These are among recent ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...